Companies β€Ί InSphero

InSphero

Healthcare πŸ“ ZΓΌrich, Switzerland πŸ‘₯ 51-200 employees πŸ’° $25.0M raised πŸ“… Founded 2009

InSphero AG develops organotypic biological 3D microtissues and microtissue-based assays for biochemical compounds screening and predictive drug testing applications. It offers human prostate and mammary carcinoma, and rat liver microtissues. The company also provides compound toxicity testing, cell-invasion assays, st

πŸ“Š Company Overview

Sector
Healthcare
Country
Switzerland
Employees
51-200
Total Raised Β· Venture
$25.0M
Founded
2009
Cloud
Unknown
Email
Microsoft 365

☁️ Cloud Infrastructure

πŸ”’ Subscribers only Cloud Provider
WorkspaceMicrosoft 365
CDNπŸ”’ Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

πŸ’° Estimated Cloud Spend

$450K – $1M / year across cloud providers

πŸ›  Tech Stack & Marketing

Ad PlatformsπŸ”’ Subscribers only
Analytics & CRMπŸ”’ Subscribers only
CMS / PlatformWordPress
Frontend StackπŸ”’ Subscribers only

Detected from InSphero's public homepage as of 2026-06-13.

πŸ” Compare with Similar Companies

Same sector (Healthcare), similar size

Data detected 2026-06-13 Β· Methodology Β· Suggest a correction